Health, Longevity & Biohacking
Peter Attia says BPC-157 still lacks published peer-reviewed human RCTs
Peter Attia Drive
403 ‒ Peptides: separating scientific promise from marketing hype
What was said
"Despite approximately three decades of claims, there are no published peer-reviewed human randomized trials demonstrating that BPC 157 accelerates healing. Three decades, dozens of fantastical benefits, and not a single human RCT?"
Peter Attia says the evidence base for BPC-157 is overwhelmingly pre-clinical and that no peer-reviewed randomised human trials show it accelerates healing. He also argues there is no clear mechanism of action, and that human safety, dosing and pharmacokinetics remain unknown.
Verification status
Attributed speaker claim
Egleze verified who said this and where. The underlying claim has not been independently established by Egleze.
Source and context
Egleze verified who said this and where. The underlying claim has not been independently established by Egleze.
- Programme
- Peter Attia Drive
- Episode
- 403 ‒ Peptides: separating scientific promise from marketing hype
- Clip time
- 15:42
- Original source
- Watch the source segment →
From this episode
Peter Attia Drive